Related references
Note: Only part of the references are listed.Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study
Haijun Tang et al.
BMC CANCER (2022)
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial
Sandro Pasquali et al.
CANCER (2022)
Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma
Tolga Koseci et al.
CLINICAL LABORATORY (2022)
The baseline neutrophil lymphocyte ratio predicts survival in soft-tissue sarcoma: A 17-year cohort study
Timothy Griffiths et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2022)
Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients
Cong Ma et al.
JOURNAL OF SURGICAL ONCOLOGY (2022)
Neutrophil-to-Lymphocyte ratio as a prognostic biomarker in extremities undifferentiated pleomorphic sarcoma
Dorian Yarih Garcia-Ortega et al.
SURGICAL ONCOLOGY-OXFORD (2022)
Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children
Haiping Ouyang et al.
FRONTIERS IN PUBLIC HEALTH (2022)
The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas
Hiromasa Yamamoto et al.
SURGERY TODAY (2021)
Pre-treatment Neutrophil-to-Lymphocyte Ratio Predicts Efficacy of Eribulin for Soft-tissue Sarcoma
Yasuyoshi Sato et al.
ANTICANCER RESEARCH (2021)
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
Eijiro Shimada et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma
Yasuyoshi Sato et al.
CANCERS (2021)
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models
Alessandro De Vita et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
Marcella Tazzari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas
D. Vinal et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma
Tao Hou et al.
EJSO (2020)
Innate inflammatory markers for predicting survival in retroperitoneal sarcoma
Yael Netanyahu et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Survival and prognostic analysis of preoperative indicators in patients undergoing surgical resections with rhabdomyosarcoma
Hongyu Jin et al.
MEDICINE (2020)
Systemic Inflammation Is Associated with Oncological Outcome in Patients with High-Grade Myxofibrosarcoma of the Extremities: A Retrospective Analysis
Andrea Sambri et al.
ONCOLOGY RESEARCH AND TREATMENT (2020)
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
Sandro Pasquali et al.
EUROPEAN JOURNAL OF CANCER (2019)
Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin
Alexandre de Nonneville et al.
CANCERS (2019)
Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study
Cem Mirili et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Prognostic analysis of surgically treated clear cell sarcoma: an analysis of a rare tumor from a single center
Shiqi Chen et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis
Xingmu Wang et al.
FRONTIERS IN ONCOLOGY (2019)
Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma
Yuan Cheng et al.
FRONTIERS IN ONCOLOGY (2019)
Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma
Hiroshi Kobayashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?
Marco Fiore et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Neutrophil/lymphocyte ratio is associated with survival in synovial sarcoma
Dorian Yarih Garcia-Ortega et al.
SURGICAL ONCOLOGY-OXFORD (2018)
Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib
Piotr Rutkowski et al.
TUMORI JOURNAL (2018)
Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas
Hiromi Sasaki et al.
NUTRIENTS (2018)
Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma The EORTC 62961-ESHO 95 Randomized Clinical Trial
Rolf D. Issels et al.
JAMA ONCOLOGY (2018)
Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib
Piotr Rutkowski et al.
TUMORI JOURNAL (2018)
Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma
Jason Yongsheng Chan et al.
SCIENTIFIC REPORTS (2018)
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres
Dario Callegaro et al.
EUROPEAN JOURNAL OF CANCER (2018)
Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection
Peng Luo et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery
Liliana Vasquez et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2017)
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study
Gemma Gatta et al.
LANCET ONCOLOGY (2017)
Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma
Yao Liang et al.
ONCOTARGET (2017)
Improved survival using specialized multidisciplinary board in sarcoma patients
J-Y Blay et al.
ANNALS OF ONCOLOGY (2017)
Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation
P. Rutkowski et al.
EJSO (2017)
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D. Demetri et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
Patrick Schoffski et al.
LANCET (2016)
Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy
Zhigang Zhang et al.
CANCER LETTERS (2015)
Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis
Tomohiro F. Nishijima et al.
CANCER TREATMENT REVIEWS (2015)
Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Espanol de Investigacion en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide
Elena Palassini et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Hemoglobin, Alkalic Phosphatase, and C-Reactive Protein Predict the Outcome in Patients With Liposarcoma
Joannis Panotopoulos et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2015)
Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
Akira Kawai et al.
LANCET ONCOLOGY (2015)
Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma
Long Jiang et al.
ONCOTARGET (2015)
Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis
Liang Zhou et al.
SCIENTIFIC REPORTS (2015)
Immune cell promotion of metastasis
Takanori Kitamura et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Elevated Preoperative Systemic Inflammatory Markers Predict Poor Outcome in Localized Soft Tissue Sarcoma
Eun-Seok Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
Joanna Szkandera et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Ian Judson et al.
LANCET ONCOLOGY (2014)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
Donald C. McMillan
CANCER TREATMENT REVIEWS (2013)
The platelet-cancer loop
Hadi A. Goubran et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma
O. K. Idowu et al.
BIOMARKERS (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Patricia Pautier et al.
ONCOLOGIST (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
The Prognostic Value of Tumor-Associated Macrophages in Leiomyosarcoma A Single Institution Study
Kristen N. Ganjoo et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
Xavier Garcia-del-Muro et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients
Soo Hyeon Lee et al.
ONCOLOGY (2011)
Contribution of platelets to tumour metastasis
Laurie J. Gay et al.
NATURE REVIEWS CANCER (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Gemcitabine at fixed dose-rate in patients with advanced soft tissue sarcomas: a mono-institutional phase II study
Virginia Ferraresi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma
Shailendra Verma et al.
CANCER TREATMENT REVIEWS (2008)
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer
Lukas A. Hefler et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic significance of macrophage infiltration in leiomyosarcomas
Cheng-Han Lee et al.
CLINICAL CANCER RESEARCH (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
C-reactive protein is a prognostic parameter in patients with cervical cancer
Stephan Polterauer et al.
GYNECOLOGIC ONCOLOGY (2007)
Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
P Allavena et al.
CANCER RESEARCH (2005)
The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8
JE De Larco et al.
CLINICAL CANCER RESEARCH (2004)
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
AT van Oosterom et al.
EUROPEAN JOURNAL OF CANCER (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial
S Frustaci et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
